Parfezine en es it fr

Parfezine Brand names, Parfezine Analogs

Parfezine Brand Names Mixture

  • No information avaliable

Parfezine Chemical_Formula

C19H24N2S

Parfezine RX_link

No information avaliable

Parfezine fda sheet

Parfezine msds (material safety sheet)

Parfezine Synthesis Reference

No information avaliable

Parfezine Molecular Weight

312.473 g/mol

Parfezine Melting Point

64.5 oC

Parfezine H2O Solubility

0.693 mg/L

Parfezine State

Solid

Parfezine LogP

5.772

Parfezine Dosage Forms

Tablet (10 mg); Tablet (scored, 50 mg)

Parfezine Indication

For use in the treatment of Parkinson's disease and also used to control severe reactions to certain medicines such as reserpine.

Parfezine Pharmacology

Ethopropazine, a phenothiazine and antidyskinetic, is used in the treatment of Parkinson's disease. By improving muscle control and reducing stiffness, this drug permits more normal movements of the body as the disease symptoms are reduced. It is also used to control severe reactions to certain medicines such as reserpine, phenothiazines, chlorprothixene, thiothixene, loxapine, and haloperidol. Unlike other NMDA antagonists, ethopropazine — because of its anticholinergic action — is largely devoid of neurotoxic side effects. Ethopropazine also has a slight antihistaminic and local anesthetic effect.

Parfezine Absorption

Well-absorbed from the gastrointestinal tract.

Parfezine side effects and Toxicity

Symptoms of overdose include severe clumsiness or unsteadiness, severe drowsiness, severe dryness of mouth, nose, or throat, fast heartbeat, shortness of breath or troubled breathing, and warmth, dryness, and flushing of skin.

Parfezine Patient Information

Parfezine Organisms Affected

Humans and other mammals